Evidence map›Paper›PMID 26976637›Full record

ArticleMolecular and cellular biology2016

p38β Mitogen-Activated Protein Kinase Modulates Its Own Basal Activity by Autophosphorylation of the Activating Residue Thr180 and the Inhibitory Residues Thr241 and Ser261.

Jonah Beenstock, Dganit Melamed, Navit Mooshayef, Dafna Mordechay, Benjamin P Garfinkel, Natalie G Ahn, Arie Admon, David Engelberg

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. p38β - MAPK11 and its role in female cancers.Journal of ovarian research · 2021
    Review
  6. Active p38α causes macrovesicular fatty liver in mice.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. p38β and Cancer: The Beginning of the Road.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Jonah BeenstockDepartment of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
Dganit MelamedFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Navit MooshayefDepartment of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel CREATE-NUS-HUJ Cellular and Molecular Mechanisms of Inflammation Program, National University of Singapore, Singapore, Singapore.
Dafna MordechayDepartment of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
Benjamin P GarfinkelDepartment of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
Natalie G AhnDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, Colorado, USA.
Arie AdmonFaculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
David EngelbergDepartment of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel CREATE-NUS-HUJ Cellular and Molecular Mechanisms of Inflammation Program, National University of Singapore, Singapore, Singapore Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore engelber@mail.huji.ac.il.
Hebrew University of Jerusalem · ILNational University of Singapore · SGTechnion – Israel Institute of Technology · ILUniversity of Colorado Boulder · US

Funding

Linking Dynamics to Catalysis and Inhibition in ERK2R01GM114594 · NIGMS · UNIVERSITY OF COLORADO · PI AHN, NATALIE G. · 2016 to 2019
$1.3M
NIGMS NIH HHS R01 GM114594
6 · The paper itself

Abstract

Many enzymes are self-regulated and can either inhibit or enhance their own catalytic activity. Enzymes that do both are extremely rare. Many protein kinases autoactivate by autophosphorylating specific sites at their activation loop and are inactivated by phosphatases. Although mitogen-activated protein kinases (MAPKs) are usually activated by dual phosphorylation catalyzed by MAPK kinases (MAPKKs), the MAPK p38β is exceptional and is capable of self-activation by cis autophosphorylation of its activation loop residue T180. We discovered that p38β also autophosphorylates in trans two previously unknown sites residing within a MAPK-specific structural element known as the MAPK insert: T241 and S261. Whereas phosphorylation of T180 evokes catalytic activity, phosphorylation of S261 reduces the activity of T180-phosphorylated p38β, and phosphorylation of T241 reduces its autophosphorylation in trans Both phosphorylations do not affect the activity of dually phosphorylated p38β. T241 of p38β is found phosphorylated in vivo in bone and muscle tissues. In myogenic cell lines, phosphorylation of p38β residue T241 is correlated with differentiation to myotubes. T241 and S261 are also autophosphorylated in intrinsically active variants of p38α, but in this protein, they probably play a different role. We conclude that p38β is an unusual enzyme that automodulates its basal, MAPKK-independent activity by several autophosphorylation events, which enhance and suppress its catalytic activity.

Indexed as

AnimalsBone and BonesCatalytic DomainCell DifferentiationCell LineFibroblastsHEK293 CellsHumansMiceMitogen-Activated Protein Kinase 11MusclesPhosphorylationSerineThreonineMitogen-Activated Protein Kinase 11SerineThreonine

Identifiers

PMID26976637
PMCPMC4859693
OpenAlexW2346682194

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.